Correlation Between Marwyn Value and AstraZeneca PLC

Can any of the company-specific risk be diversified away by investing in both Marwyn Value and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marwyn Value and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Marwyn Value Investors and AstraZeneca PLC, you can compare the effects of market volatilities on Marwyn Value and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marwyn Value with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marwyn Value and AstraZeneca PLC.

Diversification Opportunities for Marwyn Value and AstraZeneca PLC

0.09

Correlation Coefficient

Marwyn Value  AstraZeneca PLC

Significant diversification

The 3 months correlation between Marwyn and AstraZeneca is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Marwyn Value Investors and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Marwyn Value is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marwyn Value Investors are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Marwyn Value i.e., Marwyn Value and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Marwyn Value and AstraZeneca PLC

Assuming the 90 days trading horizon Marwyn Value Investors is expected to generate 0.45 times more return on investment than AstraZeneca PLC. However, Marwyn Value Investors is 2.2 times less risky than AstraZeneca PLC. It trades about -0.08 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.14 per unit of risk. If you would invest  8,944  in Marwyn Value Investors on September 5, 2024 and sell it today you would lose (344.00) from holding Marwyn Value Investors or give up 3.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Marwyn Value Investors  vs.  AstraZeneca PLC

Marwyn Value Investors

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Marwyn Value Investors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Marwyn Value is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Marwyn Value and AstraZeneca PLC

The main advantage of trading using opposite Marwyn Value and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marwyn Value position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.

The idea behind Marwyn Value Investors and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.